03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Everolimus Arrow 10mg : | |
Type | Medicine Authorised |
Originator | Afinitor 10mg |
Agent | Darapharma |
Distributor | Darapharma |
Laboratory | Arrow Génériques |
Responsible Party | Arrow Génériques |
Origin | France |
Manufacturer | Ethypharm SA |
Manufacturing Type | G |
Origin | France |
ATC | L01XE10 |
Everolimus Arrow 10mg :
Everolimus Arrow 10mg :
Everolimus Arrow 10mg :
Everolimus Arrow 10mg :
Everolimus Arrow 10mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Everolimus Arrow 10mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Acne | Common |
Acute respiratory distress syndrome | Rare |
Ageusia (Taste loss) | Uncommon |
Alopecia | Common |
ALT increased | Common |
Alveolitis | Rare |
Amenorrhoea secondary | Uncommon |
Anaemia | Very Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Aphthous stomatitis | Common |
Aplasia pure red cell (PRCA) | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Aspergillosis | Not known |
AST increased | Common |
Asthenia | Very Common |
Blood creatinine increased | Common |
Candidiasis (Candida infection) | Not known |
Congestive heart failure | Uncommon |
Conjunctivitis | Uncommon |
Cough | Common |
Decreased appetite | Very Common |
Deep vein thrombosis | Uncommon |
Dehydration | Common |
Diabetes mellitus | Common |
Diarrhoea (Diarrhea) | Very Common |
Dry mouth (Xerostomia) | Common |
Dry skin | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Common |
Dysphagia | Common |
Dyspnoea (dyspnea) | Common |
Epistaxis (Nasal bleeding) | Very Common |
Erythema | Common |
Eyelid oedema | Common |
Fatigue | Very Common |
Flushing | Uncommon |
Glossitis | Uncommon |
Glossodynia | Uncommon |
Haemoptysis | Uncommon |
Haemorrhage | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Common |
Headache | Very Common |
Hepatitis B reactivation | Not known |
Herpes zoster | Uncommon |
Hypercholesterolaemia | Very Common |
Hyperglycaemia | Very Common |
Hyperlipidaemia | Common |
Hypersensitivity | Uncommon |
Hypertension | Common |
Hypertriglyceridaemia | Common |
Hypocalcaemia | Common |
Hypokalaemia | Common |
Hypophosphataemia | Common |
Infection | Very Common |
Insomnia | Common |
Interstitial pneumonitis | Common |
Leucopenia (Leukopenia) | Common |
Lung infiltration (pulmonary infiltration) | Common |
Lymphopenia | Common |
Menstruation irregular | Common |
Mouth ulceration | Common |
Mucosal inflammation | Common |
Nail disorders | Common |
Nausea | Very Common |
Neutropenia | Common |
Non-cardiac chest pain | Uncommon |
Oedema peripheral | Very Common |
Onychoclasis | Common |
Opportunistic infections | Not known |
Oral pain | Common |
Pancytopenia | Uncommon |
Pneumocystis carinii pneumonia | Not known |
Pneumonia | Common |
Pneumonitis | Very Common |
Proteinuria | Common |
Pruritus | Very Common |
Pulmonary alveolar haemorrhage | Rare |
Pulmonary embolism | Uncommon |
Pulmonary toxicity | Rare |
Pyrexia | Common |
Renal failure | Common |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Uncommon |
Sepsis (Systemic infection) (Sepsis state) | Uncommon |
Skin exfoliation (Flaking skin) | Common |
Skin lesion | Common |
Skin rash | Very Common |
Stomatitis | Very Common |
Thrombocytopenia (Thrombopenia) | Common |
Tongue ulceration | Common |
Urine output increased | Uncommon |
Vomiting | Common |
Weight decreased (Weight loss) | Very Common |
Wound healing delayed | Rare |
Everolimus Arrow 10mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Everolimus Arrow 10mg MoH 10483 :
Form | Tablet |
Packaging | Blisters (PA/Al/PVC/Al) |
Package Size | Box of 30 |
Strength | 10mg |
Storage Condition | <25°C protect from light |
Public Price | 2111114 L.L. |
Stratum | E2 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 2420/1 |
Submission date | 02/01/2020 |
Registration Year | 14/10/2020 |
Price Comparison
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 1268.99 EUR | ( 122,934,675.24 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 42,2997 EUR | ( 4,068,792.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Tablet | |
● Package Size: | Box of 30 | |
● Public Price: | 2111114 LBP | ( 2,111,114.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 70370,47 LBP | ( 70,370.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File